account_id none on file
legal_name Tonix Pharmaceuticals Holding Corp.
ticker TNXP
cik 1430306
domain tonixpharma.com
linkedin_company_url https://www.linkedin.com/company/tonix-pharmaceuticals
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Berkeley Heights, NJ, United States
sector index/company/sector/health-care/
calls 0 filings 68 executives 7 family 0
why_nownone on file
callsnone on file
filings
due to increased clinical expenses of $1.3 million and manufacturing expenses of $4.5 million as a result of advancing our prioritized pipeline period over period, as well as increased employee-related costs of $2.5 million due to increased headcount.
filing / Aug 10, 2026 / receipt
Consumer sales discounts represent programs the Company has in place to reduce costs to the patient. This includes copay
filing / Aug 10, 2026 / receipt
result increased headcount. The table below summarizes our direct research and development expenses for our product candidates and development platform for the six months ended June 30, 2026, and 2025.
filing / Aug 10, 2026 / receipt
million collateralizes a letter of credit issued in connection with the lease of office space in Berkeley Heights, New Jersey.
filing / Aug 10, 2026 / receipt
$ 2.2 million collateralizes a letter of credit issued in connection with the lease of office space in Berkeley Heights, New Jersey
filing / Aug 10, 2026 / receipt
million collateralizes a letter of credit issued in connection with the lease of office space in Berkeley Heights, New Jersey and
filing / May 11, 2026 / receipt
million, collateralizes a letter of credit issued in connection with the lease of office space in Chatham, New Jersey and New York,
filing / May 11, 2026 / receipt
sales discounts represent programs the Company has in place to reduce costs to the patient. This includes copay buy down and eVoucher
filing / May 11, 2026 / receipt
Tonix Medicines’ Commercial Team has ~100 Years of Commercial and Launch Expertise
ir_statement / Sep 17, 2026 / receipt
Reduces internal spend
ir_statement / Sep 17, 2026 / receipt
Sales Force1 ~90 Reps Initially
ir_statement / Sep 17, 2026 / receipt
Tonix has engaged Inizio, a leading contract sales organization, to provide the majority of its sales force.
ir_statement / Sep 17, 2026 / receipt
executives
| Carolyn E. Taylor | director | - | receipt |
| James Treco | director | - | receipt |
| Jessica Morris | Chief Operating Officer | - | receipt |
| Margaret Smith Bell | director | - | receipt |
| Newcomb Stillwell | director | - | receipt |
| Richard Bagger | director | - | receipt |
| Siobhan Fogarty | Chief Technology Officer | - | receipt |
familynone on file
upcoming
changes
| 2025-02-04 | Chief Technology Officer, appointed | sec_8k |
| 2023-02-23 | director, appointed | sec_8k |
| 2021-07-19 | director, appointed | sec_8k |
| 2020-06-10 | director, appointed | sec_8k |
| 2019-02-20 | director, appointed | sec_8k |
| 2018-01-09 | Chief Operating Officer, appointed | sec_8k |
| 2018-01-09 | Chief Operating Officer, appointed | sec_8k |
| 2017-09-14 | director, appointed | sec_8k |
mcp_package_hint
slug tonix-pharmaceuticals-holding-corp
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$